v3.25.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 27, 2025
Sep. 28, 2024
Cash flows from operating activities    
Income from continuing operations $ 687 $ 684
Non-cash items:    
Depreciation and amortization 289 279
Deferred income taxes 124 (18)
Gain on business disposition (4) 0
Other, net 101 88
Changes in assets and liabilities:    
Accounts receivable, net (126) (21)
Inventories (437) (471)
Other assets (5) 170
Accounts payable 262 77
Other liabilities (46) (77)
Income taxes, net (39) 5
Pension, net (174) (169)
Captive finance receivables, net (30) 4
Other operating activities, net 11 18
Net cash provided by operating activities of continuing operations 613 569
Net cash used in operating activities of discontinued operations (1) (1)
Net cash provided by operating activities 612 568
Cash flows from investing activities    
Capital expenditures (210) (211)
Net proceeds from corporate-owned life insurance policies 77 27
Net proceeds from business disposition 16 0
Proceeds from sale of property, plant and equipment 9 3
Net cash used in business acquisitions (1) (13)
Finance receivables repaid 22 23
Finance receivables originated (40) (18)
Proceeds from the disposition of non-captive assets 66 0
Other investing activities, net 16 0
Net cash provided by (used in) investing activities (45) (189)
Cash flows from financing activities    
Proceeds from issuance of debt 495 0
Principal payments on long-term debt and nonrecourse debt (367) (375)
Purchases of Textron common stock (635) (890)
Proceeds from options exercised 25 84
Dividends paid (11) (8)
Other financing activities, net (14) (25)
Net cash used in financing activities (507) (1,214)
Effect of exchange rate changes on cash and equivalents 21 1
Net increase (decrease) in cash and equivalents 81 (834)
Cash and equivalents at beginning of period 1,441 2,181
Cash and equivalents at end of period $ 1,522 $ 1,347